AP1M2 expression levels in BLCA, BRCA, and COAD (all P < 0.0001) were all significantly and negatively related to B cells, T cells (CD4+ and CD8+), macrophages, neutrophils, and DC. Here, AP1M2 is linked to invasive breast carcinoma.